NACOLE DIAZ: Open Payments
NPI 1376926428 · MADISONVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,482 in 123 payments from 39 companies in 2025. Trend: 2023 $2,698 · 2024 $3,465 · 2025 $2,482
Food & beverage: $2,482
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $231 |
| Celgene Corporation | 11 | $202 |
| Novartis Pharmaceuticals Corporation | 10 | $193 |
| Genentech USA, Inc. | 8 | $153 |
| Merck Sharp & Dohme LLC | 5 | $121 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| ABBVIE INC. | 5 | $109 |
| PFIZER INC. | 6 | $103 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| ARRAY BIOPHARMA INC | 3 | $78 |
Products named: REBLOZYL, RYBREVANT, KISQALI, OPDIVO, Venclexta, KEYTRUDA, clonoSEQ, EPKINLY.
Industry payments across LA — which companies pay providers there.
